ArticleCancers2020

Effectiveness and Costs Associated to Adding Cetuximab or Bevacizumab to Chemotherapy as Initial Treatment in Metastatic Colorectal Cancer: Results from the Observational FABIO Project.

Matteo Franchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.